By Editor • September 4, 2026 • 1 min read
The FDA is refocusing on botanical drugs while addressing clozapine usage barriers and exploring pig kidneys for transplants.
Read moreBy Editor • September 4, 2026 • 1 min read
Walmart recalls frozen berries amid an E. coli outbreak, following an earlier recall by Publix, with consumers advised to discard the affected products.
Read moreBy Editor • September 3, 2026 • 1 min read
Ionis Pharmaceuticals' Zanvastro receives FDA approval as the first therapy for Alexander disease, showing promise in stabilizing and improving motor function.
Read moreBy Editor • September 3, 2026 • 1 min read
Horizon Organic has announced a recall of nearly 54,000 cases of chocolate milk due to spoilage concerns, marking its second recall this year.
Read moreBy Editor • September 3, 2026 • 1 min read
The FDA's TEMPO pilot program permits select AI medical devices to enter the market without prior authorization, aiding chronic condition management.
Read moreBy Editor • September 3, 2026 • 1 min read
The FDA has surprisingly made progress against unproven stem cell treatments, despite concerns raised by Robert F. Kennedy Jr.'s admissions.
Read moreBy Editor • September 1, 2026 • 2 min read
This week, the FDA has announced multiple food recalls, including items linked to salmonella and E. coli contamination, impacting various products sold nationwide.
Read moreBy Editor • August 31, 2026 • 1 min read
Bayer, Takeda, and others are part of upcoming drug pricing deals, while the FDA has approved Mimrylo for polycythemia vera.
Read moreBy Editor • August 31, 2026 • 1 min read
Retatrutide, an unapproved weight-loss drug, is enticing users like Henry, who switched from Ozempic amid concerns over safety and side effects.
Read moreBy Editor • August 30, 2026 • 1 min read
The FDA has approved rusfertide, a new treatment for polycythemia vera, a rare blood cancer that causes excessive red blood cell production.
Read more
